NCT04448457View on ClinicalTrials.gov

Sufentanil Sublingual Tablet System for Postoperative Pain Management After Total Knee Arthroplasty

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Postoperative Pain
Interventions
DRUG

Sufentanil Sublingual Tablet

15 mcg with lockout interval of 20 min

DRUG

Oxycodone oral tablet and oxycodone extended-release oral tablet

Oxycodone hydrochloride 5 mg and Oxycodone extended-release 10 mg

Trial Locations (1)

7100

Chu Tivoli, La Louvière

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Tivoli

OTHER

NCT04448457 - Sufentanil Sublingual Tablet System for Postoperative Pain Management After Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter